These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37597407)

  • 41. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assist device recipients.
    Crow S; Milano C; Joyce L; Chen D; Arepally G; Bowles D; Thomas W; Ortiz NV
    ASAIO J; 2010; 56(5):441-5. PubMed ID: 20613494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation.
    Restle DJ; Zhang DM; Hung G; Howard JL; Kallel F; Acker MA; Atluri P; Bartoli CR
    Artif Organs; 2015 Jul; 39(7):569-75. PubMed ID: 25810063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro study of red blood cell and VWF damage in mechanical circulatory support devices based on blood-shearing platform.
    Mei X; Lu B; Wu P; Zhang L
    Proc Inst Mech Eng H; 2022 Jun; 236(6):860-866. PubMed ID: 35369808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.
    Béranger N; Benghezal S; Savigny S; Capdenat S; Joly BS; Coppo P; Stepanian A; Veyradier A
    Thromb Res; 2019 Sep; 181():29-35. PubMed ID: 31330376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
    Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
    Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanistic pathway(s) of acquired von willebrand syndrome with a continuous-flow ventricular assist device: in vitro findings.
    Dassanayaka S; Slaughter MS; Bartoli CR
    ASAIO J; 2013; 59(2):123-9. PubMed ID: 23438773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Computational fluid dynamics analysis to determine shear stresses and rates in a centrifugal left ventricular assist device.
    Selgrade BP; Truskey GA
    Artif Organs; 2012 Apr; 36(4):E89-96. PubMed ID: 22360826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In Vitro Hemocompatibility Evaluation of Ventricular Assist Devices in Pediatric Flow Conditions: A Benchmark Study.
    Chan CHH; Diab S; Moody K; Frazier OH; Sampaio LC; Fraser CD; Teruya J; Adachi I
    Artif Organs; 2018 Nov; 42(11):1028-1034. PubMed ID: 30101559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pilot investigation of a novel testing strategy for bleeding in ventricular assist device recipients.
    Joyce D; Crow S; Li Z; Joyce L; Milano C; Rogers J; Villamizar-Ortiz N; Chen D
    J Heart Lung Transplant; 2012 Jul; 31(7):750-6. PubMed ID: 22538169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Individual Variability in von Willebrand Factor Fragility in Response to Shear Stress: A Possible Clue for Predicting Bleeding Risk.
    Sakatsume K; Akiyama M; Sakota D; Hijikata W; Horiuchi H; Maruyama O; Saiki Y
    ASAIO J; 2022 Sep; 68(9):1128-1134. PubMed ID: 34967782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioprosthetic Total Artificial Heart in Autoregulated Mode Is Biologically Hemocompatible: Insights for Multimers of von Willebrand Factor.
    Poitier B; Chocron R; Peronino C; Philippe A; Pya Y; Rivet N; Richez U; Bekbossynova M; Gendron N; Grimmé M; Bories MC; Brichet J; Capel A; Rancic J; Vedie B; Roussel JC; Jannot AS; Jansen P; Carpentier A; Ivak P; Latremouille C; Netuka I; Smadja DM
    Arterioscler Thromb Vasc Biol; 2022 Apr; 42(4):470-480. PubMed ID: 35139659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet Secretion Defects and Acquired von Willebrand Syndrome in Patients With Ventricular Assist Devices.
    Geisen U; Brehm K; Trummer G; Berchtold-Herz M; Heilmann C; Beyersdorf F; Schelling J; Schlagenhauf A; Zieger B
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29331958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of von Willebrand factor multimer abnormalities before and after aortic valve replacement using the Hydragel-5 assay.
    Hamiko M; Gerdes L; Silaschi M; Seidel H; Westhofen P; Kruppenbacher J; Hertfelder HJ; Oldenburg J; Bakhtiary F; Velten M; Oezkur M; Duerr GD
    Thromb Res; 2024 Jul; 241():109094. PubMed ID: 38991494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices.
    Rauch A; Legendre P; Christophe OD; Goudemand J; van Belle E; Vincentelli A; Denis CV; Susen S; Lenting PJ
    Thromb Haemost; 2014 Nov; 112(5):1014-23. PubMed ID: 25030452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies.
    Favaloro EJ; Oliver S; Mohammed S; Vong R
    Haemophilia; 2020 May; 26(3):503-512. PubMed ID: 32159272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI.
    Lukito P; Wong A; Jing J; Arthur JF; Marasco SF; Murphy DA; Bergin PJ; Shaw JA; Collecutt M; Andrews RK; Gardiner EE; Davis AK
    J Thromb Haemost; 2016 Nov; 14(11):2253-2260. PubMed ID: 27601054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of surface roughness on the damage of von Willebrand Factor under shear flow condition.
    Mei X; Lu B; Zhong M; Zhu Y; Zhang L; Ge W
    Int J Artif Organs; 2022 Apr; 45(4):412-420. PubMed ID: 34736346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acquired von Willebrand Syndrome and Platelet Function Defects during Extracorporeal Life Support (Mechanical Circulatory Support).
    Schlagenhauf A; Kalbhenn J; Geisen U; Beyersdorf F; Zieger B
    Hamostaseologie; 2020 Jun; 40(2):221-225. PubMed ID: 32455462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of shear stress on device-induced platelet hemostatic dysfunction relevant to thrombosis and bleeding in mechanically assisted circulation.
    Chen Z; Zhang J; Li T; Tran D; Griffith BP; Wu ZJ
    Artif Organs; 2020 May; 44(5):E201-E213. PubMed ID: 31849074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support.
    Vincent F; Rauch A; Loobuyck V; Robin E; Nix C; Vincentelli A; Smadja DM; Leprince P; Amour J; Lemesle G; Spillemaeker H; Debry N; Latremouille C; Jansen P; Capel A; Moussa M; Rousse N; Schurtz G; Delhaye C; Paris C; Jeanpierre E; Dupont A; Corseaux D; Rosa M; Sottejeau Y; Barth S; Mourran C; Gomane V; Coisne A; Richardson M; Caron C; Preda C; Ung A; Carpentier A; Hubert T; Denis C; Staels B; Lenting PJ; Van Belle E; Susen S
    J Am Coll Cardiol; 2018 May; 71(19):2106-2118. PubMed ID: 29747831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.